These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24314241)

  • 21. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.
    Cools J; Wlodarska I; Somers R; Mentens N; Pedeutour F; Maes B; De Wolf-Peeters C; Pauwels P; Hagemeijer A; Marynen P
    Genes Chromosomes Cancer; 2002 Aug; 34(4):354-62. PubMed ID: 12112524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma.
    Mao X; Orchard G; Lillington DM; Russell-Jones R; Young BD; Whittaker S
    Genes Chromosomes Cancer; 2003 Jun; 37(2):176-85. PubMed ID: 12696066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain metastasis of ALK positive anaplastic large cell lymphoma after a long-term disease free survival in an old adult.
    Wang CX; Wang H; Li J; Ma HH; Yu B; Shi SS; Zhou XJ; Shi QL
    Int J Clin Exp Pathol; 2014; 7(3):1182-7. PubMed ID: 24696735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes.
    Lamant L; de Reyniès A; Duplantier MM; Rickman DS; Sabourdy F; Giuriato S; Brugières L; Gaulard P; Espinos E; Delsol G
    Blood; 2007 Mar; 109(5):2156-64. PubMed ID: 17077326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Co-expression of CD99/MIC2 and ALK in anaplastic large-cell lymphoma tissues and its significance].
    Zhong L; Wei QZ; Huang XP; Ji TH; Li F; Wang ZQ; Li XZ; Liu JH; Zhao T
    Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):173-6. PubMed ID: 22781601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetics of anaplastic large cell lymphoma.
    Zeng Y; Feldman AL
    Leuk Lymphoma; 2016; 57(1):21-7. PubMed ID: 26104084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases.
    Agrawal K; Shet T; Sridhar E; Dhende S; Sengar M; Arora B; Laskar S; Gujral S; Menon H; Banavali S
    Indian J Pathol Microbiol; 2017; 60(4):533-540. PubMed ID: 29323068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaplastic large cell lymphoma, ALK-positive.
    Ferreri AJ; Govi S; Pileri SA; Savage KJ
    Crit Rev Oncol Hematol; 2012 Aug; 83(2):293-302. PubMed ID: 22440390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Array-CGH analysis of cutaneous anaplastic large cell lymphoma.
    Szuhai K; van Doorn R; Tensen CP; Van Kester
    Methods Mol Biol; 2013; 973():197-212. PubMed ID: 23412792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anaplastic large cell lymphoma in leukemic phase: extraordinarily high white blood cell count.
    Nguyen JT; Condron MR; Nguyen ND; De J; Medeiros LJ; Padula A
    Pathol Int; 2009 May; 59(5):345-53. PubMed ID: 19432678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
    Pittaluga S; Wlodarska I; Pulford K; Campo E; Morris SW; Van den Berghe H; De Wolf-Peeters C
    Am J Pathol; 1997 Aug; 151(2):343-51. PubMed ID: 9250148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas.
    Boi M; Zucca E; Inghirami G; Bertoni F
    Br J Haematol; 2015 Mar; 168(6):771-83. PubMed ID: 25559471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of fluorescent in situ hybridization for detection of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma.
    Johnson PW; Leek J; Swinbank K; Angus B; Roberts P; Markham AF; Selby PJ; MacLennan KA
    Ann Oncol; 1997; 8 Suppl 2():65-9. PubMed ID: 9209644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma.
    Boi M; Rinaldi A; Kwee I; Bonetti P; Todaro M; Tabbò F; Piva R; Rancoita PM; Matolcsy A; Timar B; Tousseyn T; Rodríguez-Pinilla SM; Piris MA; Beà S; Campo E; Bhagat G; Swerdlow SH; Rosenwald A; Ponzoni M; Young KH; Piccaluga PP; Dummer R; Pileri S; Zucca E; Inghirami G; Bertoni F
    Blood; 2013 Oct; 122(15):2683-93. PubMed ID: 24004669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular cytogenetic aberrations in CD30+ anaplastic large cell lymphoma cell lines.
    Gogusev J; Telvi L; Nezelof C
    Cancer Genet Cytogenet; 2002 Oct; 138(2):95-101. PubMed ID: 12505251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistopathological features of anaplastic large-cell lymphoma according to anaplastic lymphoma kinase expression and bone marrow involvement pattern.
    Park SH; Chi HS; Cho YU; Jang S; Park CJ
    Histopathology; 2013 Jul; 63(1):13-8. PubMed ID: 23656317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALK expression plays different roles in anaplastic large-cell lymphomas and outcome of crizotinib use in relapsed/refractory ALK+ patients in a Chinese population.
    Huang L; Zhang F; Zeng J; Guo H; Liu S; Wei X; Chen F; Jiang X; Liang Z; Liu Y; Li W
    Ann Hematol; 2018 Jan; 97(1):149-159. PubMed ID: 29150811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative.
    Kadin ME; Pinkus JL; Pinkus GS; Duran IH; Fuller CE; Onciu M; Kawaguchi H; Morris SW
    Am J Surg Pathol; 2008 Sep; 32(9):1421-6. PubMed ID: 18670345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of ALK gene alterations in urothelial carcinoma.
    Bellmunt J; Selvarajah S; Rodig S; Salido M; de Muga S; Costa I; Bellosillo B; Werner L; Mullane S; Fay AP; O'Brien R; Barretina J; Minoche AE; Signoretti S; Montagut C; Himmelbauer H; Berman DM; Kantoff P; Choueiri TK; Rosenberg JE
    PLoS One; 2014; 9(8):e103325. PubMed ID: 25083769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The heterogeneous landscape of ALK negative ALCL.
    Mereu E; Pellegrino E; Scarfò I; Inghirami G; Piva R
    Oncotarget; 2017 Mar; 8(11):18525-18536. PubMed ID: 28061468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.